Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
AUTOR(ES)
Coller, B S
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=507964Documentos Relacionados
- Antagonistas do receptor plaquetário GPIIb/IIIa
- Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke
- Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.
- Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells.
- Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro